 |
인쇄하기
취소
|
Major firms forecast to suffer profit loss in third quarter
Major Korean pharmaceutical companies are likely to see their third-quarter operating profit worsen, buffeted by tough regulation and their difficulty in reducing promotional expenses, analysts said recently.
According to analysts, Green Cross is expected to post its third quarter earnings with higher revenue by 25 percent from a year earlier and operating profit by 7.3 percent.
In contra...
According to analysts, Green Cross is expected to post its third quarter earnings with higher revenue by 25 percent from a year earlier and operating profit by 7.3 percent.
In contra...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.